Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply
N Engl J Med
.
2022 Jun 30;386(26):2535.
doi: 10.1056/NEJMc2205618.
Epub 2022 Jun 15.
Authors
Susan Hopkins
1
,
Victoria Hall
1
,
Paul Klenerman
2
Affiliations
1
U.K. Health Security Agency, London, United Kingdom susan.hopkins1@ukhsa.gov.uk.
2
University of Oxford, Oxford, United Kingdom.
PMID:
35704418
DOI:
10.1056/NEJMc2205618
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
SARS-CoV-2*
Spike Glycoprotein, Coronavirus
Vaccination
Substances
COVID-19 Vaccines
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2